When asked what he was doing on the roof of the White House press briefing room, Trump replied: “Taking a little walk.” …
In a market of 20%+ yields, where should you be investing?
If your investment does not deliver returns above inflation, you’re effectively losing money. In today’s environment, that bar is set …
Sensex trades below 80,700 level; Titan, Maruti, IndusInd lead gainers, pharma stocks drag
Equity benchmark indices stage volatility — though off the day’s lows — during the mid-session on Tuesday, as investor sentiment remained under pressure further
Decoding Riot Platforms’s Options Activity: What’s the Big Picture?
Today, Benzinga’s options scanner spotted 9 options trades for Riot Platforms. This is not a typical pattern. The sentiment among these major traders is
Wall Street Journal Delivers Reality Check To MAGA: ‘Maybe Hold The Euphoria’
The Wall Street Journal on Monday urged caution among Donald Trump supporters who are all whipped up over his sweeping new tariffs on imports
Donald Trump’s DOJ May Release Ghislaine Maxwell Interview: Reports
The push to make the transcript public comes amid pressure from Trump allies and the House GOP to unseal related grand jury materials.
The Stock Market Is Stuck Between Good Earnings and Bad Data. How the Tension Gets Resolved.
I nvestors are struggling with a contradiction at the heart of the market as stocks move into their toughest months of the year. On
Multibagger stock Tiger Logistics jumps 4% despite sell-off in the Indian stock market. Do you own it?
Stock Market Today: Multibagger stock Tiger Logistics gains 4% during the intraday trades on Tuesday despite the sell-off in the Indian stock market. Do
Indian stock market: Can Sensex, Nifty bounce back if RBI pulls a surprise rate cut for 2nd time in a row?
Indian stock market: Reserve Bank of India (RBI) governor Sanjay Malhotra has demonstrated a penchant for surprising financial markets, especially through bold rate and
Vertex Stock Tumbles 15% After Strong Earnings. What’s Spooking Investors.
Vertex Pharmaceuticals stock fell after quarterly earnings and revenue beat analysts’ expectations, overshadowed by bad news on its pain drug VX-993.